PocDoc chosen as one of 5 companies to participate in the Global Heart Health Catalyst Biome programme

PocDoc Selected for Global Heart Health Catalyst Biome Programme: A Leap Forward in Cardiovascular Care

PocDoc Joins Global Leaders

BIG ANNOUNCEMENT: PocDoc has been honored with selection as one of five companies to participate in the Global Heart Health Catalyst Biome programme. The initiative is a collaboration between Novartis UK, Medtronic, Chelsea and Westminster Hospital NHS Foundation Trust, and RYSE Asset Management.

Being chosen for this innovative programme symbolizes recognition from global leaders in pharmaceuticals and medical devices, along with one of the UK's most pioneering hospital trusts. It underscores the critical importance of PocDoc's contributions to heart health technology.

PocDoc's selection is a testament to our dedication to innovation in heart health. Our unique approach aligns perfectly with the programme's goals of improving at-home testing and early detection of cardiovascular issues.

CEO Steve Roest's Pitch

Our CEO, Steve Roest, will be taking the stage at #hett22 on Tuesday at 2 pm. He will be presenting PocDoc's vision and detailing how our technology fits into this groundbreaking initiative.